MondegarAI
VIKING GLOBAL INVESTORS LP

Q2 2024 · 13F-HR

VIKING GLOBAL INVESTORS LPholdings as filed

Filed 2024-08-14 · accession 0000905148-24-002226

$26.02B
Reported value
82
Positions
2024-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
023135106AMZNAMAZON COM INC$1.80B6.90%9,293,613CommonSOLE
00724F101ADBEADOBE INC$1.26B4.86%2,276,627CommonSOLE
718172109PMPHILIP MORRIS INTL INC$1.11B4.25%10,912,378CommonSOLE
594918104MSFTMICROSOFT CORP$1.02B3.94%2,292,331CommonSOLE
00187Y100APGAPI GROUP CORP$1.02B3.91%27,032,516CommonSOLE
902973304USBUS BANCORP DEL$1.01B3.88%25,404,913CommonSOLE
037833100AAPLAPPLE INC$966.9M3.72%4,590,693CommonSOLE
98138H101WDAYWORKDAY INC$885.3M3.40%3,959,965CommonSOLE
517834107LVSLAS VEGAS SANDS CORP$875.5M3.36%19,785,682CommonSOLE
743315103PGRPROGRESSIVE CORP$832.3M3.20%4,006,859CommonSOLE
34959J108FTVFORTIVE CORP$743.9M2.86%10,039,510CommonSOLE
G76279101ROIVROIVANT SCIENCES LTD$731.0M2.81%69,155,846CommonSOLE
256746108DLTRDOLLAR TREE INC$727.0M2.79%6,808,797CommonSOLE
10806X102BBIOBRIDGEBIO PHARMA INC$636.3M2.45%25,120,991CommonSOLE
64110L106NFLXNETFLIX INC$629.6M2.42%932,867CommonSOLE
46625H100JPMJPMORGAN CHASE & CO.$608.8M2.34%3,009,822CommonSOLE
25809K105DASHDOORDASH INC$602.2M2.31%5,535,921CommonSOLE
09061G101BMRNBIOMARIN PHARMACEUTICAL INC$581.5M2.24%7,063,564CommonSOLE
40415F101HDBHDFC BANK LTD$563.3M2.16%8,756,864CommonSOLE
580135101MCDMCDONALDS CORP$478.1M1.84%1,876,019CommonSOLE
11135F101AVGOBROADCOM INC$470.6M1.81%293,097CommonSOLE
872590104TMUST-MOBILE US INC$439.2M1.69%2,492,802CommonSOLE
36828A101GEVGE VERNOVA INC$416.5M1.60%2,428,614CommonSOLE
03076C106AMPAMERIPRISE FINL INC$388.3M1.49%909,020CommonSOLE
133131102CPTCAMDEN PPTY TR$355.7M1.37%3,259,567CommonSOLE
G3421J106FERG1GBXFERGUSON PLC NEW$324.1M1.25%1,673,699CommonSOLE
12504L109CBRECBRE GROUP INC$322.6M1.24%3,620,575CommonSOLE
G7709Q104RPRXROYALTY PHARMA PLC$315.7M1.21%11,970,058CommonSOLE
049468101TEAMATLASSIAN CORPORATION$259.3M1.00%1,465,977CommonSOLE
35671D857FCXFREEPORT-MCMORAN INC$254.2M0.98%5,229,917CommonSOLE
29452E101EQHEQUITABLE HLDGS INC$239.4M0.92%5,859,547CommonSOLE
345370860FFORD MTR CO DEL$235.6M0.91%18,789,638CommonSOLE
91324P102UNHUNITEDHEALTH GROUP INC$225.0M0.86%441,795CommonSOLE
461202103INTUINTUIT$220.8M0.85%335,994CommonSOLE
00404A109ACHCACADIA HEALTHCARE COMPANY IN$218.6M0.84%3,236,785CommonSOLE
40412C101HCAHCA HEALTHCARE INC$210.2M0.81%654,167CommonSOLE
23804L103DDOGDATADOG INC$178.5M0.69%1,376,071CommonSOLE
67066G104NVDANVIDIA CORPORATION$171.0M0.66%1,384,547CommonSOLE
88579Y101MMM3M CO$168.0M0.65%1,644,145CommonSOLE
126408103CSXCSX CORP$158.5M0.61%4,738,544CommonSOLE
N62509109NAMSNEWAMSTERDAM PHARMA COMPANY$154.2M0.59%8,024,565CommonSOLE
H42097107UBSUBS GROUP AG$152.7M0.59%5,186,506CommonSOLE
758750103RRXREGAL REXNORD CORPORATION$151.9M0.58%1,123,163CommonSOLE
46120E602ISRGINTUITIVE SURGICAL INC$150.3M0.58%337,893CommonSOLE
L8681T102SPOTSPOTIFY TECHNOLOGY S A$149.0M0.57%474,981CommonSOLE
29414B104EPAMEPAM SYS INC$142.3M0.55%756,261CommonSOLE
30303M102METAMETA PLATFORMS INC$134.3M0.52%266,259CommonSOLE
16119P108CHTRCHARTER COMMUNICATIONS INC N$131.1M0.50%438,601CommonSOLE
532457108LLYELI LILLY & CO$130.5M0.50%144,175CommonSOLE
45826H109ITGRINTEGER HLDGS CORP$128.7M0.49%1,111,779CommonSOLE
824348106SHWSHERWIN WILLIAMS CO$121.7M0.47%407,786CommonSOLE
03769M106APOAPOLLO GLOBAL MGMT INC$114.7M0.44%971,224CommonSOLE
00650F109ADPTADAPTIVE BIOTECHNOLOGIES COR$108.6M0.42%29,993,708CommonSOLE
79466L302CRMSALESFORCE INC$104.2M0.40%405,135CommonSOLE
34385P108LABSTANDARD BIOTOOLS INC$103.8M0.40%58,651,170CommonSOLE
687793109OSCROSCAR HEALTH INC$93.8M0.36%5,928,038CommonSOLE
74275K108PCORPROCORE TECHNOLOGIES INC$91.1M0.35%1,374,580CommonSOLE
020002101ALLALLSTATE CORP$87.0M0.33%545,182CommonSOLE
58155Q103MCKMCKESSON CORP$83.0M0.32%142,169CommonSOLE
338307101FIVNFIVE9 INC$76.5M0.29%1,734,414CommonSOLE
629377508NRGNRG ENERGY INC$73.5M0.28%943,457CommonSOLE
92686J106VKTXVIKING THERAPEUTICS INC$71.8M0.28%1,354,450CommonSOLE
146869102CVNACARVANA CO$71.3M0.27%553,621CommonSOLE
457669307INSMINSMED INC$69.4M0.27%1,035,970CommonSOLE
N69605108PHVSPHARVARIS N V$68.7M0.26%3,653,310CommonSOLE
35104E100FDMT4D MOLECULAR THERAPEUTICS IN$61.6M0.24%2,934,914CommonSOLE
45258J102IMVTIMMUNOVANT INC$61.3M0.24%2,320,902CommonSOLE
92537N108VRTVERTIV HOLDINGS CO$59.7M0.23%689,687CommonSOLE
48251W104KKRKKR & CO INC$57.4M0.22%545,092CommonSOLE
37611X100DNA4EURGINKGO BIOWORKS HOLDINGS INC$47.8M0.18%143,085,126CommonSOLE
54300N103LONGBOARD PHARMACEUTICALS IN$44.8M0.17%1,658,962CommonSOLE
50212V100LPLALPL FINL HLDGS INC$36.3M0.14%130,000CommonSOLE
98887Q104ZLABZAI LAB LTD$35.3M0.14%2,037,374CommonSOLE
23954D109DAWNGBXDAY ONE BIOPHARMACEUTICALS I$35.3M0.14%2,558,563CommonSOLE
68622P109ORICORIC PHARMACEUTICALS INC$28.3M0.11%4,000,000CommonSOLE
781154109RBRKRUBRIK INC.$27.5M0.11%897,170CommonSOLE
28036F105EWTXEDGEWISE THERAPEUTICS INC$26.7M0.10%1,481,146CommonSOLE
45720N103INBXINHIBRX BIOSCIENCES INC$25.3M0.10%1,787,705CommonSOLE
713317105PEPGPEPGEN INC$23.7M0.09%1,482,434CommonSOLE
80105N105SNYSANOFI$15.8M0.06%326,290CommonSOLE
89532M101TRVITREVI THERAPEUTICS INC$13.1M0.05%4,400,000CommonSOLE
75120L100RALLYBIO CORP$5.6M0.02%4,194,777CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.